Maravai LifeSciences Holdings, Inc. MRVI EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s EBITDA margin?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported EBITDA margin of -57.7% in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s EBITDA margin changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s EBITDA margin increased by 35.5% year-over-year, from -89.5% to -57.7%.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s EBITDA margin?
- Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s EBITDA margin has grown at a 11.6% compound annual growth rate (CAGR), from 51% to -88.2%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.